EP Patent

EP3876937A1 — Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdose

Assigned to Indivior Inc · Expires 2021-09-15 · 5y expired

What this patent protects

Methods, pharmaceutical formulations and devices for the preventative treatment of incidental opioid overdose comprising the intramuscular or subcutaneous administration using an auto- injection device of a pharmaceutical formulation containing the opioid antagonist nalmefene as …

USPTO Abstract

Methods, pharmaceutical formulations and devices for the preventative treatment of incidental opioid overdose comprising the intramuscular or subcutaneous administration using an auto- injection device of a pharmaceutical formulation containing the opioid antagonist nalmefene as a prophylactic measure.

Drugs covered by this patent

Patent Metadata

Patent number
EP3876937A1
Jurisdiction
EP
Classification
—
Expires
2021-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Indivior Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.